venerdì, Aprile 12, 2024
Home 2021 Luglio

Monthly Archives: Luglio 2021

Moderna amplia il suo studio sul vaccino COVID-19 nei bambini più piccoli per rilevare...

0
Moderna ha detto lunedì che prevede di espandere le dimensioni del suo studio sul vaccino COVID-19 nei bambini più piccoli per rilevare meglio gli effetti collaterali rari, come un tipo di infiammazione cardiaca recentemente...

Moderna expand its COVID-19 vaccine study in younger children to better detect rare side...

0
Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S....

The benefits of developing COVID-19 vaccines delivered in an intranasal mist

0
A microbiologist and an immunologist from the University of Alabama at Birmingham have published a Perspective piece in the journal Science outlining the possible benefits of developing COVID-19 vaccines delivered in an intranasal mist...

Sinopharm vaccine offers poor protection from COVID-19 among the elderly

0
A new study suggests that a Sinopharm vaccine offers poor protection from COVID-19 among the elderly, raising questions for dozens of countries that have given the Chinese company's shots to their most vulnerable populations. A...

COVID-19: Why Do Some People Get Seriously Ill?

0
The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new study in the journal Cell suggests that the first responses in this battleground help...

The efficacy of Loncastuximab tesirine to treat aggressive B-cell lymphoma

0
MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to test the efficacy of Loncastuximab tesirine, a promising new treatment for aggressive B-cell lymphoma....

Il COVID-19 aumenta l’iperglicemia dopo l’infezione

0
I ricercatori stanno osservando un nuovo problema di salute a lungo termine nei pazienti ricoverati in ospedale con COVID-19 : un aumento dell'iperglicemia di nuova insorgenza che dura mesi dopo l'infezione. Uno studio italiano ha rilevato che circa la...

COVID-19 increase hyperglycemia after infection

0
Researchers are observing a new long-term health concern in patients hospitalized with COVID-19 - an increase in new-onset hyperglycemia lasting months after infection. An Italian study found that about half of the patients admitted to...

L’azitromicina antibiotica non è risultata più efficace di un placebo nel prevenire i sintomi...

0
Uno studio della UC San Francisco ha scoperto che l'antibiotico azitromicina non era più efficace di un placebo nel prevenire i sintomi di  COVID-19 tra i pazienti non ricoverati  e potrebbe aumentare le loro possibilità di...

Antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19...

1
A UC San Francisco study has found that the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19 among non-hospitalized patients, and may increase their chance of hospitalization, despite widespread prescription...

Cancer: new strategy for treating the most aggressive and untreatable forms of the disease

0
All cancers fall into just two categories, according to new research from scientists at Sinai Health, in findings that could provide a new strategy for treating the most aggressive and untreatable forms of the...

I ricercatori mostrano come SARS-CoV-2 infetta le cellule cerebrali

0
I ricercatori della University of California San Diego School of Medicine e del Rady Children’s Institute for Genomic Medicine hanno prodotto un modello di cellule staminali che dimostra una potenziale via di ingresso del SARS-CoV-2 ,...

Researchers shows how SARS-CoV-2 infects brain cells

0
Researchers at University of California San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus...

New blood test can measure the amount of SARS-CoV-2 neutralizing antibodies present in the...

1
The Lausanne University Hospital (CHUV) and EPFL teamed up to develop a new test that's sensitive enough to measure the amount of SARS-CoV-2 neutralizing antibodies present in the bloodstream. The scientists' discovery, published in...

COVID-19: RBD recombinant protein using the yeast expression platform would meet the demand for...

0
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be easy to...